Left temporal perfusion associated with suspiciousness score on the Brief Psychiatric Rating Scale in schizophrenia

Psychiatry Research - Neuroimaging

Volumn 147, Issue 2-3, 2006, Pages 163-171

  Kohno, Tomoya ^a   Shiga, Tohru ^a   Kusumi, Ichiro ^a   Matsuyama, Tetsuaki ^a   Kageyama, Hiroyuki ^a   Katoh, Chietsugu ^a   Koyama, Tsukasa ^a   Tamaki, Nagara ^a  

^a HOKKAIDO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Cerebral blood flow; Left temporal lobe; Schizophrenia; Suspiciousness

Indexed keywords

CHLORPROMAZINE; IODINE 123; RADIOISOTOPE;

ADOLESCENT; ADULT; ARTICLE; BRAIN BLOOD FLOW; BRAIN PERFUSION; BRIEF PSYCHIATRIC RATING SCALE; CINGULATE GYRUS; CLINICAL ARTICLE; COMPUTER PROGRAM; CORRELATION ANALYSIS; DELUSION; DISEASE SEVERITY; FEMALE; HUMAN; MALE; PHOTON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; RATING SCALE; SCHIZOPHRENIA; SCORING SYSTEM; STATISTICAL ANALYSIS; STATISTICAL SIGNIFICANCE; SYMPTOM; TEMPORAL CORTEX;

ADOLESCENT; ADULT; BRIEF PSYCHIATRIC RATING SCALE; CEREBROVASCULAR CIRCULATION; FEMALE; FUNCTIONAL LATERALITY; HUMANS; MALE; MIDDLE AGED; PERSONALITY DISORDERS; SCHIZOPHRENIA; SCHIZOPHRENIC PSYCHOLOGY; SEVERITY OF ILLNESS INDEX; TEMPORAL LOBE; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON;

EID: 33748689300     PISSN: 09254927     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pscychresns.2006.01.016     Document Type: Article

References (57)

1. Alberici A., Gobbo C., Panzacchi A., Nicosia F., Ghidoni R., Benussi L., Hock C., Papassotiropoulos A., Liberini P., Growdon J.H., Frisoni G.B., Villa A., Zanetti O., Cappa S., Fazio F., and Binetti G. Frontotemporal dementia: impact of P301L tau mutation on a healthy carrier. Journal of Neurology, Neurosurgery and Psychiatry 75 (2004) 1607-1610
2. American Psychiatric Association. DSM-IV. Diagnostic and Statistical Manual of Mental Disorders. 4th ed. (1994), APA, Washington, DC
3. Andreasen N.C. The Scale for the Assessment of Positive Symptoms (SAPS) (1984), University of Iowa, Iowa City
4. Andreasen N.C., O'Leary D.S., Flaum M., Nopoulos P., Watkins G.L., Boles-Ponto L.L., and Hichwa R.D. Hypofrontality in schizophrenia: distributed dysfunctional circuits in neuroleptic-naive patients. Lancet 349 (1997) 1730-1734
5. Bense S., Deutschlander A., Stephan T., Bartenstein P., Schwaiger M., Brandt T., and Dieterich M. Preserved visual-vestibular interaction in patients with bilateral vestibular failure. Neurology 63 (2004) 122-128
6. Berman I., Merson A., Sison C., Allan E., Schaefer C., Loberboym M., and Losonczy M.F. Regional cerebral blood flow changes associated with risperidone treatment in elderly schizophrenia patients: a pilot study. Psychopharmacology Bulletin 32 (1996) 95-100
7. Bertolino A., Blasi G., Caforio G., Latorre V., De Candia M., Rubino V., Callicott J.H., Mattay V.S., Bellomo A., Scarabino T., Weinberger D.R., and Nardini M. Functional lateralization of the sensorimotor cortex in patients with schizophrenia: effects of treatment with olanzapine. Biological Psychiatry 56 (2004) 190-197
8. Catafau A.M., Parellada E., Lomen-a F.J., Bernardo M., Pavia J., Ros D., Setoain J., and González-Monclus E. Prefrontal and temporal blood flow in schizophrenia: resting and activation technetium-99m-HMPAO SPECT patterns in young neuroleptic-naive patients with acute disease. Journal of Nuclear Medicine 35 (1994) 935-941
9. Chang L.T. A method for attenuation correction in radionuclide computed tomography. IEEE Transactions on Nuclear Science 25 (1978) 638-643
10. Chiu N.T., Lee B.F., Hsiao S., and Pai M.C. Educational level influences regional cerebral blood flow in patients with Alzheimer's disease. Journal of Nuclear Medicine 45 (2004) 1860-1863
11. Copolov D.L., Seal M.L., Maruff P., Ulusoy R., Wong M.T., Tochon-Danguy H.J., and Egan G.F. Cortical activation associated with the experience of auditory hallucinations and perception of human speech in schizophrenia: a PET correlation study. Psychiatry Research: Neuroimaging 122 (2003) 139-152
12. Erkwoh R., Sabri O., Steinmeyer E.M., Bull U., and Sass H. Psychopathological and SPECT findings in never-treated schizophrenia. Acta Psychiatrica Scandinavica 96 (1997) 51-57
13. Friston K.J. Commentary and opinion: II. Statistical parametric mapping: ontology and current issues. Journal of Cerebral Blood Flow and Metabolism 15 (1995) 361-370
14. Ganguli R., Singh A., Brar J., Carter C., and Mintun M. Hydrocortisone induced regional cerebral activity changes in schizophrenia: a PET scan study. Schizophrenia Research 56 (2002) 241-247
15. Grabowski T.J., Damasio H., Eichhorn G.R., and Tranel D. Effects of gender on blood flow correlates of naming concrete entities. Neuroimage 20 (2003) 940-954
16. Honey G.D., Sharma T., Suckling J., Giampietro V., Soni W., Williams S.C., and Bullmore E.T. The functional neuroanatomy of schizophrenic subsyndromes. Psychological Medicine 33 (2003) 1007-1018
17. Inagaki A., Inada T., and Fujii Y. Equivalent Dose of Psychotropics (1999), Seiwa Shoten, Tokyo
18. Inagaki A., Inada T., and Fujii Y. Dose equivalence of psychotropic drugs: Part XV. Dose equivalence of novel neuroleptics. Perospirone. Japanese Journal of Clinical Pharmacology 4 (2001) 869-870
19. Jaeger J.J., Lockwood A.H., Van Valin Jr. R.D., Kemmerer D.L., Murphy B.W., and Wack D.S. Sex differences in brain regions activated by grammatical and reading tasks. Neuroreport 9 (1998) 2803-2807
20. Jibiki I., Matsuda H., Yamaguchi N., Kurokawa K., and Hisada K. Acutely administered haloperidol-induced widespread reduction of regional cerebral blood flow observed from subtraction of brain imaging with single photon emission computed tomography using technetium-99m hexamethyl-propyleneamine oxime. Neuropsychobiology 24 (1990-1991) 125-128
21. Kane J., Honigfeld G., Singer J., and Meltzer H. Clozapine for the treatment-resistant schizophrenic: a double-blind comparison with chlorpromazine. Archives of General Psychiatry 45 (1988) 789-796
22. Kitamura T., Machizawa S., Maruyama S., Nakagawa Y., Morita M., and Sato T. Test-retest reliability of Oxford University version of the Brief Psychiatric Rating Scale (BPRS): a preliminary survey of multicenter collaborative study initiated by the National Institute of Mental Health. Journal of Mental Health 32 (1985) 1-15
23. Kolakowska T. Brief Psychiatric Rating Scale: Glossaries and Rating Instructions (1976), Oxford University Press, Oxford
24. Kosaka H., Omori M., Murata T., Iidaka T., Yamada H., Okada T., Takahashi T., Sadato N., Itoh H., Yonekura Y., and Wada Y. Differential amygdala response during facial recognition in patients with schizophrenia: an fMRI study. Schizophrenia Research 57 (2002) 87-95
25. Krausz Y., Freedman N., Lester H., Newman J.P., Barkai G., Bocher M., Chisin R., and Bonne O. Regional cerebral blood flow in patients with mild hypothyroidism. Journal of Nuclear Medicine 45 (2004) 1712-1715
26. Kwon J.S., McCarley R.W., Hirayasu Y., Anderson J.E., Fischer I.A., Kikinis R., Jolesz F.A., and Shenton M.E. Left planum temporale volume reduction in schizophrenia. Archives of General Psychiatry 56 (1999) 142-148
27. Lewis S.W., Ford R.A., Syed G.M., Reveley A.M., and Toone B.U. A controlled study of Tc-99m-HMPAO single-photon emission imaging in chronic schizophrenia. Psychological Medicine 22 (1992) 27-35
28. Liddle P.F., Friston K.J., Frith C.D., Hirsch S.R., Jones T., and Frackowiak R.S. Patterns of cerebral blood flow in schizophrenia. British Journal of Psychiatry 160 (1992) 179-186
29. Lindauer R.J., Booij J., Habraken J.B., Uylings H.B., Olff M., Carlier I.V., den Heeten G.J., van Eck-Smit B.L., and Gersons B.P. Cerebral blood flow changes during script-driven imagery in police officers with posttraumatic stress disorder. Biological Psychiatry 56 (2004) 853-861
30. Malaspina D., Perera G.M., Lignelli A., Marshall R.S., Esser P.D., Storer S., Furman V., Wray A.D., Coleman E., Gorman J.M., and Van Heertum R.L. SPECT imaging of odor identification in schizophrenia. Psychiatry Research: Neuroimaging 82 (1998) 53-61
31. Malaspina D., Storer S., Furman V., Esser P., Printz D., Berman A., Lignelli A., Gorman J., and Van Heertum R. SPECT study of visual fixation in schizophrenia and comparison subjects. Biological Psychiatry 46 (1999) 89-93
32. Malaspina D., Harkavy-Friedman J., Corcoran C., Mujica-Parodi L., Printz D., Gorman J.M., and Van Heertum R. Resting neural activity distinguishes subgroups of schizophrenia patients. Biological Psychiatry 56 (2004) 931-937
33. Martin J.A., and Penn D.L. Attributional style in schizophrenia: an investigation in outpatients with and without persecutory delusions. Schizophrenia Bulletin 28 (2002) 131-141
34. Min S.K., An S.K., Jon D.I., and Lee J.D. Positive and negative symptoms and regional cerebral perfusion in antipsychotic-naive schizophrenic patients: a high-resolution SPECT study. Psychiatry Research: Neuroimaging 90 (1999) 159-168
35. Mitelman S.A., Shihabuddin L., Brickman A.M., Hazlett E.A., and Buchsbaum M.S. MRI assessment of gray and white matter distribution in Brodmann's areas of the cortex in patients with schizophrenia with good and poor outcomes. American Journal of Psychiatry 160 (2003) 2154-2168
36. Molina V., Gispert J.D., Reig S., Sanz J., Pascau J., Santos A., Palomo T., and Desco M. Cerebral metabolism and risperidone treatment in schizophrenia. Schizophrenia Research 60 (2003) 1-7
37. Molina V., Gispert J.D., Reig S., Pascau J., Martinez R., Sanz J., Palomo T., and Desco M. Olanzapine-induced cerebral metabolic changes related to symptom improvement in schizophrenia. International Clinical Psychopharmacology 20 (2005) 13-18
38. Molina V., Gispert J.D., Reig S., Sanz J., Pascau J., Santos A., Desco M., and Palomo T. Cerebral metabolic changes induced by clozapine in schizophrenia and related to clinical improvement. Psychopharmacology 178 (2005) 17-26
39. Overall J.E., and Gorham D.R. The Brief Psychiatric Rating Scale. Psychological Reports 10 (1962) 799-812
40. Parellada E., Catafau A.M., Bernardo M., Lomena F., Catarineu S., and Gonzalez-Monclus E. The resting and activation issue of hypofrontality: a single photon emission computed tomography study in neuroleptic-naive and neuroleptic-free schizophrenic female patients. Biological Psychiatry 44 (1998) 787-790
41. Potkin S.G., Alva G., Fleming K., Anand R., Keator D., Carreon D., Doo M., Jin Y., Wu J.C., and Fallon J.H. A PET study of the pathophysiology of negative symptoms in schizophrenia. Positron emission tomography. American Journal of Psychiatry 159 (2002) 227-237
42. Puri B.K., Lekh S.K., Nijran K.S., Bagary M.S., and Richardson A.J. SPECT neuroimaging in schizophrenia with religious delusions. International Journal of Psychophysiology 40 (2001) 143-148
43. Pyne J.M., Bean D., and Sullivan G. Characteristics of patients with schizophrenia who do not believe they are mentally ill. Journal of Nervous and Mental Disease 189 (2001) 146-153
44. Ragland J.D., Coleman A.R., Gur R.C., Glahn D.C., and Gur R.E. Sex differences in brain-behavior relationships between verbal episodic memory and resting regional cerebral blood flow. Neuropsychologia 38 (2000) 451-461
45. Ragland J.D., Gur R.C., Raz J., Schroeder L., Kohler C.G., Smith R.J., Alavi A., and Gur R.E. Effect of schizophrenia on frontotemporal activity during word encoding and recognition: a PET cerebral blood flow study. American Journal of Psychiatry 158 (2001) 1114-1125
46. Robinson D., Woerner M.G., Alvir J.M., Bilder R., Goldman R., Geisler S., Koreen A., Sheitman B., Chakos M., Mayerhoff D., and Lieberman J.A. Predictors of relapse following response from a first episode of schizophrenia or schizoaffective disorder. Archives of General Psychiatry 56 (1999) 241-247
47. Sabri O., Erkwoh R., Schreckenberger M., Owega A., Sass H., and Buell U. Correlation of positive symptoms exclusively to hyperperfusion or hypoperfusion of cerebral cortex in never-treated schizophrenics. Lancet 349 (1997) 1735-1739
48. Salgado-Pineda P., Junque C., Vendrell P., Baeza I., Bargallo N., Falcon C., and Bernardo M. Decreased cerebral activation during CPT performance: structural and functional deficits in schizophrenic patients. Neuroimage 21 (2004) 840-847
49. 123I-IMP brain perfusion SPET with the triple energy window method in normal subjects using SPM analysis. European Journal of Nuclear Medicine and Molecular Imaging 29 (2002) 342-345
50. Suhara T., Okubo Y., Yasuno F., Sudo Y., Inoue M., Ichimiya T., Nakashima Y., Nakayama K., Tanada S., Suzuki K., Halldin C., and Farde L. Decreased dopamine D2 receptor binding in the anterior cingulate cortex in schizophrenia. Archives of General Psychiatry 59 (2002) 25-30
51. 11C]WAY-100635. Archives of General Psychiatry 59 (2002) 514-520
52. Thermenos H.W., Seidman L.J., Breiter H., Goldstein J.M., Goodman J.M., Poldrack R., Faraone S.V., and Tsuang M.T. Functional activity during auditory verbal working memory in nonpsychotic relatives of persons with schizophrenia: a pilot study. Biological Psychiatry 55 (2004) 490-500
53. 123I]Iomazenil SPECT benzodiazepine receptor imaging in schizophrenia. Psychiatry Research: Neuroimaging 91 (1999) 163-173
54. 2A receptor changes in schizophrenia. Psychiatry Research: Neuroimaging 99 (2000) 123-135
55. Vita A., Bressi S., Perani D., Invernizzi G., Giobbio G.M., Dieci M., Garbarini M., Del Sole A., and Fazio F. High-resolution SPECT study of regional cerebral blood flow in drug-free and drug-naive schizophrenic patients. American Journal of Psychiatry 152 (1995) 876-882
56. 2 receptor binding in subregions of the thalamus in schizophrenia. American Journal of Psychiatry 161 (2004) 1016-1022
57. Yuasa S., Kurachi M., Suzuki M., Kadono Y., Matsui M., Saitoh O., and Seto H. Clinical symptoms and regional cerebral blood flow in schizophrenia. European Archives of Psychiatry and Clinical Neuroscience 246 (1995) 7-12